BibTex format
@article{Monaghan:2019:10.1080/19490976.2018.1506667,
author = {Monaghan, T and Mullish, BH and Patterson, J and Wong, GK and Marchesi, JR and Xu, H and Jilani, T and Kao, D},
doi = {10.1080/19490976.2018.1506667},
journal = {Gut Microbes},
pages = {142--148},
title = {Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathway.},
url = {http://dx.doi.org/10.1080/19490976.2018.1506667},
volume = {10},
year = {2019}
}
RIS format (EndNote, RefMan)
TY - JOUR
AB - The mechanisms of efficacy for fecal microbiota transplantation (FMT) in treating recurrent Clostridioides difficile infection (rCDI) remain poorly defined, with restored gut microbiota-bile acid interactions representing one possible explanation. Furthermore, the potential implications for host physiology of these FMT-related changes in gut bile acid metabolism are also not well explored. In this study, we investigated the impact of FMT for rCDI upon signalling through the farnesoid X receptor (FXR)-fibroblast growth factor (FGF) pathway. Herein, we identify that in addition to restoration of gut microbiota and bile acid profiles, FMT for rCDI is accompanied by a significant, sustained increase in circulating levels of FGF19 and reduction in FGF21. These FGF changes were associated with weight gain post-FMT, to a level not exceeding the pre-rCDI baseline. Collectively, these data support the hypothesis that the restoration of gut microbial communities by FMT for rCDI is associated with an upregulated FXR-FGF pathway, and highlight the potential systemic effect of FMT.
AU - Monaghan,T
AU - Mullish,BH
AU - Patterson,J
AU - Wong,GK
AU - Marchesi,JR
AU - Xu,H
AU - Jilani,T
AU - Kao,D
DO - 10.1080/19490976.2018.1506667
EP - 148
PY - 2019///
SP - 142
TI - Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathway.
T2 - Gut Microbes
UR - http://dx.doi.org/10.1080/19490976.2018.1506667
UR - https://www.ncbi.nlm.nih.gov/pubmed/30183484
UR - http://hdl.handle.net/10044/1/62888
VL - 10
ER -